Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

C
C. Lourenço, Eva

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Eva C. Lourenço
Favorite
Cady, Andrea

Thermo Fisher Scientific
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Andrea Cady
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Andrea Cady
Favorite
Cahill, Heather

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Heather Cahill
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Heather Cahill
Favorite
Cai, Hao

Genentech, Inc.
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Hao Cai
Favorite
Caisse, Philippe

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Philippe Caisse
Favorite
Cai, Yuncheng

Huazhong University of Science and Technology
(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity
Yuncheng Cai
Favorite
Calderon, Marcelo

University of the Basque Country
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Marcelo Calderon
Favorite
Callahan, Jordan

Aprecia Pharmaceuticals Company
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Jordan Callahan
Favorite
Campbell, Beverley

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Beverley Campbell
Favorite
Campbell, Joey

Prolytix
(M1330-10-58) A Multiple Component, Indirect Analysis of Ammonium: Analysis of Sulfate Ion in a Commercial Biotherapeutic via HPLC to Measure Ammonium Content
Joey Campbell
Favorite
Campos-Teran, Jose

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Jose Campos-Teran
Favorite
Canally, Caroline

Moderna Therapeutics
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Caroline Canally
Favorite
Cancino, Nicolas

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Nicolas Cancino
Favorite
Cano, Chris

TFF Pharmaceuticals, Inc.
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Chris Cano
Favorite
Cao, Albert

University of Michigan
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Albert Cao
Favorite
Cappucci, Mark

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Mark Cappucci
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Mark Cappucci
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Mark Cappucci
Favorite
Caratozzolo, Anders

BioAgilytix
(M1230-03-18) Multimodal Immunogene Therapy via Nanoparticle Delivery System
Anders Caratozzolo
Favorite
Carbol, Jason

Dow Development Laboratories, LLC
(M1330-09-49) Eliminating Operator Dependence from Gelling Agent Addition - Improving the Robustness and Processing Time of Semi-Solid Dosage Forms Without Impacting the Viscosity or Aesthetics
Jason Carbol
Favorite
(T1230-07-41) Assessing the Impact of Cryo-Freezing in Different Topical Formulations
Jason Carbol
Favorite
(W0930-09-50) Determining the Most Suitable Gelling Agent for Topical Semi-Solid Formulation Development- An Investigation into the Physical Robustness of Various Gelling Agents
Jason Carbol
Favorite
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jason Carbol
Favorite
Cardot, Jean-Michel

Borvo
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Jean-Michel Cardot
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Jean-Michel Cardot
Favorite
Carnes, Katie

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Katie Carnes
Favorite
Carrier, Rebecca

Northeastern University
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Rebecca Carrier
Favorite
Casadevall, Gemma

Nutraresearch
(T1530-01-01) Proven New Sustainable Eco-Friendly Packaging for Challenging Formulation Compositions
Gemma Casadevall
Favorite
Cassidy, Kenneth

Eli Lilly and Company
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Kenneth Cassidy
Favorite
Castiglioni, Alessandra

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Alessandra Castiglioni
Favorite
Castillo, Kevin

Biopact LLC
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Kevin Castillo
Favorite
Castro, monica

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
monica Castro
Favorite
Catalano, Carlos

University of Colorado
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Carlos Catalano
Favorite
Catarata, Ruginn

St. John's University
(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer
Ruginn Catarata
Favorite
Cave, Joseph

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Joseph Cave
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Joseph Cave
Favorite
Cedran Coco, Julia

University of Campinas
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Julia Cedran Coco
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Julia Cedran Coco
Favorite
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Julia Cedran Coco
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Julia Cedran Coco
Favorite
Ceulemans, Jens

Janssen Pharceutica NV
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Jens Ceulemans
Favorite
Chacra, Nadia

Universidade de Sao Paulo
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Nadia Chacra
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Nadia Chacra
Favorite
Chadwick, Jessica

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Jessica Chadwick
Favorite
Chahley, Nick

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Nick Chahley
Favorite
Chai, Lili

ICE Bioscience
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Lili Chai
Favorite
Chakka, Jaidev

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Jaidev Chakka
Favorite
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Jaidev Chakka
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Jaidev Chakka
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Jaidev Chakka
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Jaidev Chakka
Favorite
(W1230-11-63) A Novel First-in-Class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
Jaidev Chakka
Favorite
Chak, Vincent

University at Buffalo
(W0930-02-12) Oral Tolerance Mediated by Phosphatidylserine Containing Lipid Nanoparticle
Vincent Chak
Favorite
Cha, Kwangho

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Kwangho Cha
Favorite
Chal, Ben

Gilead Sciences, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Ben Chal
Favorite
Chan, Brian

Rutgers, The State University of New Jersey
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Brian Chan
Favorite
Chan, Chun Man Jones

Prince of Wales Hospital, Hospital Authority
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Chun Man Jones Chan
Favorite
Chanda, Arani

Sarepta Therapeutics
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Arani Chanda
Favorite
Chandran, Uma

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Uma Chandran
Favorite
Chandrashekar, Aishwarya

University of Michigan
(M1430-09-49) Remote Encapsulation of Exenatide in PLGA Microspheres Using Cationic Excipients
Aishwarya Chandrashekar
Favorite
Chang, Calvin

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Calvin Chang
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Calvin Chang
Favorite
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Calvin Chang
Favorite
Chang-Guo, Zhan

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Zhan Chang-Guo
Favorite
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Zhan Chang-Guo
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Zhan Chang-Guo
Favorite
Chang, Rui

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Rui Chang
Favorite
Chan, Ho Yin Edwin

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Ho Yin Edwin Chan
Favorite
Chan, Larry

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Larry Chan
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Larry Chan
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Larry Chan
Favorite
Chao, Chih-Jia

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Chih-Jia Chao
Favorite
Chapa, Revathi

Simulations Plus, Inc.
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Revathi Chapa
Favorite
Chapdelaine, John

Pharmascience Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
John Chapdelaine
Favorite
Chapman, Jerry

Redica Systems
(T1330-11-63) Developing a Risk Score for Critical Suppliers Using Artificial Intelligence (AI)
Jerry Chapman
Favorite
Chatterjee, Kaustav

Merck & Co., Inc.
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Kaustav Chatterjee
Favorite
Chatterjee, Parnali

US Food and Drug Administration
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Parnali Chatterjee
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Parnali Chatterjee
Favorite
Chaturvedi, Kaushalendra

J-Star Research
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Kaushalendra Chaturvedi
Favorite
Chaturvedi, Kaushalendra

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Kaushalendra Chaturvedi
Favorite
Chaudhuri, Bodhisattwa

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Bodhisattwa Chaudhuri
Favorite
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Bodhisattwa Chaudhuri
Favorite
Chauhan, Anjali

Pharmaeutical Sciences Northeastern University
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Anjali Chauhan
Favorite
Chauhan, Neha

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Neha Chauhan
Favorite
Chaulagain, Bivek

North Dakota State University
(T1030-04-19) Cannabidiol and BDNF-Encapsulated Brain-Targeted Lipid Nanoparticles Reduce Inflammation, Lower Pathological Amyloid and Tau Levels, and Improve Cognition in Transgenic Models of Alzheimer’s disease
Bivek Chaulagain
Favorite
Chavan, Neelam

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Neelam Chavan
Favorite
Chavan, Tejashri

Kenox Pharmaceuticals Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Tejashri Chavan
Favorite
Chawareeyawong, Pai

23andMe Inc.
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Pai Chawareeyawong
Favorite
Chen, Aochiu

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Aochiu Chen
Favorite
Chen, David

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
David Chen
Favorite
Chendo, Catarina

Hovione
(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products
Catarina Chendo
Favorite
Chen, Elva

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Elva Chen
Favorite
Cheng, Celine

Hong Kong Pharmaceutical Manufacturers Association
(M1130-11-62) Network Analysis of Pharmaceutical Products from Hong Kong PIC/S GMP Manufacturers
Celine Cheng
Favorite
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Celine Cheng
Favorite
Cheng, Hao

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Hao Cheng
Favorite
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Hao Cheng
Favorite
(W0930-06-35) Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies
Hao Cheng
Favorite
Cheng, Joan

University of Minnesota
(M1430-07-37) Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro BBB Model
Joan Cheng
Favorite
Cheng, Ming

Boehringer Ingelheim
(T1430-02-12) Ocular Pharmacokinetic Model for Intravitreal Antibody Injection
Ming Cheng
Favorite
Cheng, Rui

Wake Forest University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Rui Cheng
Favorite
cheng, yuan

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
yuan cheng
Favorite
Cheng, Yu-En

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Yu-En Cheng
Favorite
Chen, Hongyu

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Hongyu Chen
Favorite
Chen, Hui

Chinese Academy of Science
(T1230-01-03) A High Oral Bioavailable Berberine-Lornoxicam Cocrystal with Improved Caco-2 Permeability, Tunable Dissolution, and Improved Taste
Hui Chen
Favorite
Chen, HuiLing

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
HuiLing Chen
Favorite
Chen, Hunter

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Hunter Chen
Favorite
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Hunter Chen
Favorite
Chen, Ida

Dow Chemical Company
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Ida Chen
Favorite
Chen, Jing

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Jing Chen
Favorite
Chen, Julie

HORIBA
(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration
Julie Chen
Favorite
Chen, Kun

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Kun Chen
Favorite
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Kun Chen
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Kun Chen
Favorite
Chen, Lih-Geeng

National Chiayi University
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Lih-Geeng Chen
Favorite
Chen, Pengyu

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Pengyu Chen
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Pengyu Chen
Favorite
Chen, Qing

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Qing Chen
Favorite
Chen, Shirley

Binghamton university
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Shirley Chen
Favorite
Chen, Shiuan-Yin

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Shiuan-Yin Chen
Favorite
Chen, Tina

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Tina Chen
Favorite
Chen, Tse-Hong

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Tse-Hong Chen
Favorite
Chen, Weiqiang

New York University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Weiqiang Chen
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Weiqiang Chen
Favorite
Chen, Yih-Wen

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Yih-Wen Chen
Favorite
Chen, Yuan

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Yuan Chen
Favorite
Chen, Ziting

University of Michigan
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Ziting Chen
Favorite
Cheong, Fook Chiong

Spheryx, Inc.
(M1030-11-60) Detecting and Identifying Contaminants for Root Cause Analysis: Distinguishing Free Fatty Acid Breakdown Products of Surfactants, Silicone Oil and Protein Aggregates
Fook Chiong Cheong
Favorite
Cheon, Seunghyun

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Seunghyun Cheon
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Seunghyun Cheon
Favorite
Cherif, Achref

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Achref Cherif
Favorite
(T0930-03-14) Toward Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding and Cryogenic Milling
Achref Cherif
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Achref Cherif
Favorite
Cheu, Ryan

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Ryan Cheu
Favorite
Chevrier, Anik

Polytechnique Montreal
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Anik Chevrier
Favorite
Chevrier, Stephanie

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Stephanie Chevrier
Favorite
Chhibber, Tanya

University of Utah
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Tanya Chhibber
Favorite
Chiang, Yi-Hua

University of Florida
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Yi-Hua Chiang
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Yi-Hua Chiang
Favorite
Chiap, Patrice

Academic Hospital of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Patrice Chiap
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Patrice Chiap
Favorite
Chi, Chun-Wei

University at Buffalo
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Chun-Wei Chi
Favorite
Chilamula, Srikanth

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Srikanth Chilamula
Favorite
Chilewski, Shannon

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Shannon Chilewski
Favorite
Chiluisa, Anelis

Eli Lilly and Company
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Anelis Chiluisa
Favorite
Chinnici, Caitlin

Syneos Health
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Caitlin Chinnici
Favorite
Chitnis, Kshitij

University of Mississippi
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Kshitij Chitnis
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Kshitij Chitnis
Favorite
Cho, Dea Jin

Il-Yang Pharm
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Dea Jin Cho
Favorite
Cho, Hyeongeun (Tony)

Northeastern University
(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging
Hyeongeun (Tony) Cho
Favorite
Cho, Hyunah

St. John's University
(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin
Hyunah Cho
Favorite
Choi, Han-Gon

Hanyang University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Han-Gon Choi
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Han-Gon Choi
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Han-Gon Choi
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Han-Gon Choi
Favorite
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Han-Gon Choi
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Han-Gon Choi
Favorite
Choi, Heejae

Yonsei University
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Heejae Choi
Favorite
Choi, Seo-Hyeong

Gangnam Weedahm Korean Medicine Hospital
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Seo-Hyeong Choi
Favorite
Choo, Gwangho

Daewoong Pharmaceutical Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Gwangho Choo
Favorite
Chopski, Steven

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Steven Chopski
Favorite
Choudhary, Narmada

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Narmada Choudhary
Favorite
Choudhary, Suman

St. John's University
(W1030-03-18) Exploring the Potential of Inhaled Clofazimine Liposomes for Mesothelioma Treatment
Suman Choudhary
Favorite
Choudhury, Samrat

University of Mississippi
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Samrat Choudhury
Favorite
Chougule, Mahavir

Mercer University
(T1230-06-34) PEGylated Nanoparticles Conjugated with LHRH Receptor Binding Peptide for Treatment of Lung Cancer
Mahavir Chougule
Favorite
Chouirfa, Hamza

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Hamza Chouirfa
Favorite
Chow, Diana S.L.

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Diana S.L. Chow
Favorite
Cho, William C.S.

Queen Elizabeth Hospital
(M1530-02-11) Circumvention of Targeted Anticancer Drug Resistance by Standardized Yunzhi Extract
William C.S. Cho
Favorite
Chow, Keat Theng

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Keat Theng Chow
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Keat Theng Chow
Favorite
Cho, Yejin

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Yejin Cho
Favorite
Choy, Robert K.M.

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Robert K.M. Choy
Favorite
Christian E, Ogaugwu

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Ogaugwu Christian E
Favorite
Chui, Cherry

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Cherry Chui
Favorite
Chung, Cindy

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Cindy Chung
Favorite
Chung, Hee Sun

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Hee Sun Chung
Favorite
Chure, Chetan

Contract Pharmaceuticals Limited
(M1030-05-29) Preparation and Characterization of Pregabalin Loaded Liposomes for Topical Drug Delivery: Utilizing the Novel Platform Technology for the Effective Treatment of Neuropathic Pain Management
Chetan Chure
Favorite
(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches
Chetan Chure
Favorite
Chu, Xiaoyan

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Xiaoyan Chu
Favorite
Chvila, Stanislav

University of Chemistry and Technology
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Stanislav Chvila
Favorite
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Stanislav Chvila
Favorite
Clark, Abe

University of North Texas Health Science Center
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Abe Clark
Favorite
Clark, Andrew

digiM Solution
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Andrew Clark
Favorite
Clarke, Samuel

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Samuel Clarke
Favorite
Clark, Richard

NeoMatrix Therapeutics, Inc.
(M1130-02-11) Toxicokinetics of cNP8, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Richard Clark
Favorite
(M1330-02-11) Toxicokinetics of cP12, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Richard Clark
Favorite
Claude, Emmanuelle

Waters Corporation
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Emmanuelle Claude
Favorite
Cleary, Hannah

Trinity College Dublin
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Hannah Cleary
Favorite
Clements, Brianna

Waters Corporation
(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Brianna Clements
Favorite
Clerman, Andrew

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Andrew Clerman
Favorite
Clikeman, Tyler

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Tyler Clikeman
Favorite
Cloake, Edward

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Edward Cloake
Favorite
Cojocariu, Cristian

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Cristian Cojocariu
Favorite
Colandene, James

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
James Colandene
Favorite
Colletti, Kelly

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Kelly Colletti
Favorite
Collins, Mary

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Mary Collins
Favorite
Colombo, Gaia

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Gaia Colombo
Favorite
Colombo, Paolo

University of Parma
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Paolo Colombo
Favorite
Columba-Palomares, Maria Crystal

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Maria Crystal Columba-Palomares
Favorite
Concannon, Amy

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Amy Concannon
Favorite
Cone, Roger

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
Roger Cone
Favorite
Confer, Alex

Merck & Co., Inc.
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Alex Confer
Favorite
Conner, Kip

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Kip Conner
Favorite
Cook, Kevin

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Kevin Cook
Favorite
Cooley, Megan

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Megan Cooley
Favorite
Cooper, Bailey

Regeneron Pharmaceuticals
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Bailey Cooper
Favorite
Coralie, Schneider

BASF SE
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Schneider Coralie
Favorite
Corbeil, Sophie

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Sophie Corbeil
Favorite
Corbo, Julie

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Julie Corbo
Favorite
Cornell, Tom

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Tom Cornell
Favorite
Cornett, Taylor

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Taylor Cornett
Favorite
Corona-Gomez, Lysett

National Autonomous University of Mexico
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Lysett Corona-Gomez
Favorite
Corrado, Tanner

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Tanner Corrado
Favorite
Cortes-Nunez, Samaria

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Samaria Cortes-Nunez
Favorite
Costa, Eunice

Hovione FarmaCiencia SA
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Eunice Costa
Favorite
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Eunice Costa
Favorite
Cotrim, Joana

Hovione
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Joana Cotrim
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Joana Cotrim
Favorite
Cottingham, Andrea

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Andrea Cottingham
Favorite
Cotton, Joanne

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Joanne Cotton
Favorite
Coulter, Don

University of Nebraska Medical Center
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Don Coulter
Favorite
Cousineau, Christopher

Arrowhead Pharmaceuticals
(M1030-06-35) Development and Optimization of a Highly Sensitive and Selective Anion Exchange Liquid Chromatography with Fluorescence Detection Assay for Quantitation of siRNA Oligonucleotide Therapeutic Compounds
Christopher Cousineau
Favorite
Cowans, Brett

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Brett Cowans
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Brett Cowans
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Brett Cowans
Favorite
Cox, Elizabeth

Alcami Corporation
(M1330-04-24) High-Performance Liquid Chromatography Method with Refractive-Index Detection for Quantitation of Memantine Hydrochloride in Memantine Hydrochloride Extended-Release Dissolution Samples
Elizabeth Cox
Favorite
Crampon, Eric

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Eric Crampon
Favorite
Crawford, Lisa

Moderna Therapeutics
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Lisa Crawford
Favorite
Crawford, Mitch

Freund-Vector Corporation
(M1430-10-54) Designing Spray Dried Particles with a Pressure Nozzle at Small Scale
Mitch Crawford
Favorite
Craye, Goedele

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Goedele Craye
Favorite
Crean, Abina

University College Cork
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Abina Crean
Favorite
Cristóvão, Joana

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Joana Cristóvão
Favorite
Cristini, Vittorio

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Vittorio Cristini
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Vittorio Cristini
Favorite
Cristofoletti, Rodrigo

University of Florida
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Rodrigo Cristofoletti
Favorite
Croom, Jordan

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Jordan Croom
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Jordan Croom
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Jordan Croom
Favorite
Cross, Donna

University of Utah
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Donna Cross
Favorite
Crowell, Eric

University of Texas at Austin
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Eric Crowell
Favorite
(T1430-01-05) Formulation Development of Novel PLGA-Based Long-Acting Monolithic Implant
Eric Crowell
Favorite
Croyle, Maria

University of Texas at Austin
(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration
Maria Croyle
Favorite
(T1030-05-28) Characterizing the Effects of a Novel Surfactant on Growth Inhibition and Preservation of Different Bacterial Species
Maria Croyle
Favorite
Croy, Scott

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Scott Croy
Favorite
Cruz, Eric

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Eric Cruz
Favorite
Cruz, Matthew

Merck & Co., Inc.
(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions
Matthew Cruz
Favorite
Cui, Dapeng

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Dapeng Cui
Favorite
Cui, Haixi

University of Maryland, Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Haixi Cui
Favorite
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Haixi Cui
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Haixi Cui
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Haixi Cui
Favorite
Cui, Yi

Wake Forest University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Yi Cui
Favorite
Cui, Zhengrong

University of Texas at Austin
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Zhengrong Cui
Favorite
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Zhengrong Cui
Favorite
Cui, Zhiyi

GSK
(T1330-02-07) Translational PK/PD Modeling to Predict Human PK and Treg Depletion of a Monoclonal Antibody Based on Preclinical Data
Zhiyi Cui
Favorite
Cunha Filho, Marcilio

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Marcilio Cunha Filho
Favorite
Cunningham, Charlie

Colorcon, Inc.
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Charlie Cunningham
Favorite
Curran, Geoffry

Mayo Clinic
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Geoffry Curran
Favorite
Curry, Stacy

North Texas Eye Research Institute
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Stacy Curry
Favorite
Cushing, Matt

Nelson Labs
(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS
Matt Cushing
Favorite
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Matt Cushing
Favorite
Cusin, Lucas

Evonik Corporation
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Lucas Cusin
Favorite
Custodio, Joseph

Corcept Therapeutics
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Joseph Custodio
Favorite
Czeskis, Boris

Eli Lilly and Company
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Boris Czeskis
Favorite